Esta página foi traduzida automaticamente e a precisão da tradução não é garantida. Por favor, consulte o versão em inglês para um texto fonte.

Using Narrative Exposure Therapy to Treat Violent Offenders With Post Traumatic Stress and Emotion Dysregulation.

11 de novembro de 2026 atualizado por: University of Lincoln

Using Narrative Exposure Therapy to Treat Violent Offenders With Post Traumatic Stress and Emotion Dysregulation: A Single Case Study Series.

The purpose of this study is to find out whether a therapy called Narrative Exposure Therapy (NET) is suitable and could be helpful for people who:

  • have experienced trauma
  • find it hard to manage their emotions
  • have a history of violent offending

NET is already used in clinical practice, but there is limited research about how helpful it is for this group. This study will look at whether NET:

  • is feasible to use in this population
  • reduces symptoms of post-traumatic stress (such as nightmares, flashbacks, and feeling on edge)
  • helps people manage their emotions better What is NET? NET is a one-to-one talking therapy for people who have experienced trauma. In NET, the patient and the therapist create a timeline of your life. This includes both positive experiences and difficult or traumatic events. individuals then talk through the traumatic events in a safe and structured way, with support from the therapist.

The aim is to help the brain process these memories so they cause less distress in everyday life. NET focuses on you as a whole person, not just on your offending history.

Visão geral do estudo

Descrição detalhada

Trauma, emotion regulation and offending Individuals within the offending population have experienced more adverse childhood experiences (ACE's) and traumatic life events than those within the general population, indicating that experiences of post-traumatic stress may be more prevalent within this group when compared to the prevalence in the general population. Despite this, diagnosis of Post Traumatic Stress Disorder often goes undiagnosed and untreated within the offending population.

Emotion Regulation is defined as the ability to inhibit and maintain emotional expressions. ICD - 11 indicates for a diagnosis for Complex Post Traumatic Stress Disorder there should be difficulties in emotion regulation present . This is further evidenced by Cloitre et.al. who indicated that Adverse Childhood Experiences and prolonged trauma in childhood may lead to difficulties in emotion regulation. Thus, if levels of ACE's and traumatic life events are more prevalent in offending populations, this may indicate potential difficulties in emotion regulation.

Post traumatic stress and Heart Rate Variability (HRV) Post Traumatic Stress is identified as a cluster of symptoms that are associated with the diagnosis of PTSD. These symptoms include intrusions such as flashbacks and nightmares, avoidance, changes in cognition and mood such as negative thoughts about self or the world and arousal and reactivity for example being easily startled or on edge. Despite the experience of post traumatic stress being common in offending populations, PTSD often goes undiagnosed.

HRV refers to the fluctuation of heart rate over a period and is used as a physiological marker of mental wellbeing. HRV reflects the balance of the sympathetic and parasympathetic systems held within the autonomic nervous system. An increase in anxiety is reflected in reduced HRV, which indicates an increase in heart rate meaning that the sympathetic and parasympathetic systems are in acting parsimoniously. The ICD-10 recognises increased arousal as a post traumatic stress symptom, indicating increases in anxiety are related to post traumatic stress, thus reduced HRV. Research has shown alterations in HRV among individuals with PTSD, specifically, PTSD has been associated with reduced HRV, similar to the findings with anxiety. The reduced HRV observed in PTSD patients may be a physiological manifestation of this heightened stress state that is associated with post-traumatic stress. Thus, measuring HRV is a sufficient way of measuring distress associated with post - traumatic stress via physiological symptomology which is less subjective.

What is Narrative Exposure Therapy? Narrative Exposure Therapy (NET) is a short-term specific trauma therapy recommended by the National Institute for Health and Care Excellence (NICE) for work with refugees. NET was developed based on experiences seen in refugees and victims of torture. The researchers found that developing a narrative timeline of the victim's trauma, helped reduce post-traumatic stress symptoms and increased hope. In NET, individuals talk through a chronological narrative timeline of their life experiences, with the aim to reconstruct fragmented trauma memories into coherent narrative memories that are contextualised in the time and space that they originally happened. This is achieved by tapping into the fear network, the cognitive, emotional and sensory bodily memories of the trauma and connecting these memories to the chronological time that they happened, allowing for processing of the trauma memory and a more coherent, less fragmented life story being formed. Patients are encouraged to relive the emotions felt by the memory whilst staying connected to the present thus reminding the patient that the feelings are because of the memory, making episodic links to "then" and "now" . Furthermore, NET also works on the process of habituation, which means exposing yourself to the trauma memory, not avoiding it. This allows individuals to change their beliefs about the trauma memory by learning that the anxiety they feel when exposed to the memory will reduce (Lord, 2023), thus they will habituate to the memory.

Previous Research in NET NET has an increasing evidence base across various populations and has gained support in its treatment for CPTSD. NET has been shown to be potentially effective in reducing post-traumatic stress in various populations including refugees, women who have experienced Interpersonal Violence and veterans. An adapted version of NET (FORNET) has been shown to be a superior treatment in improving PTSD, aggression and depression in child soldiers. Thus, research has indicated the use of NET may be appropriate for those who have experienced traumatic life events and have potentially committed violence within the past. There is little evidence supporting the use of non-adapted NET in adults who have offended, thus further research is needed to investigate whether NET would be helpful in this population.

NET has also been evidenced to have less attrition than other trauma therapies when working with individuals with complex trauma histories, and NET is seen as the superior treatment for these individuals, this suggests that NET may be beneficial for those with complex trauma such as ACE's and interpersonal childhood trauma, which is often seen in offending populations.

Rationale for study This research aims to inform the growing research base of using NET within various populations. The results of this research have implications for further research into using NET within this population, which could indicate other potential positive outcomes such as decreased reoffending and use of services, which would decrease burden on already overstretched services. Despite the lack of research into using Narrative Exposure Therapy within offending populations, the intervention is starting to be used in practice and therefore research into this area is important to inform evidence-based practice. Furthermore, a lot of treatment focus for offenders is on managing forensic risk and is not person centred, often leaving the individual feeling that what has happened to them is not important. Research suggests that post traumatic stress is a risk factor for violent behaviour, thus indicating that a focus on trauma rather than risk may be beneficial for those who have committed violent offences in reducing risk but also improving mental wellbeing. Moreover, as NET encourages a complete view of a person's timeline, not just highlighting negative events but positive life events too, this minimises the emphasis on solely negative life experiences. This allows individuals to consider positives parts of their lives, rather than just negative life events and trauma, which is often a difficulty experienced in forensic populations due to the nature of the population

The purpose of this investigation is to understand whether NET is feasible to use within the population of violent offenders. We aim to investigate this by looking at its impact on experiences of post - traumatic stress and ability to regulate emotion. We also aim to look at participant experiences of NET, to inform whether this intervention is acceptable to use in this population and is accessible for them. This knowledge would inform further investigations into the potential effectiveness of NET within this population.

Tipo de estudo

Intervencional

Inscrição (Estimado)

6

Estágio

  • Não aplicável

Contactos e Locais

Esta seção fornece os detalhes de contato para aqueles que conduzem o estudo e informações sobre onde este estudo está sendo realizado.

Contato de estudo

Estude backup de contato

Locais de estudo

      • Lincoln, Reino Unido
        • Recrutamento
        • Community Forensic Team
        • Contato:
        • Investigador principal:
          • Rebecca Watson

Critérios de participação

Os pesquisadores procuram pessoas que se encaixem em uma determinada descrição, chamada de critérios de elegibilidade. Alguns exemplos desses critérios são a condição geral de saúde de uma pessoa ou tratamentos anteriores.

Critérios de elegibilidade

Idades elegíveis para estudo

18 anos e mais velhos (Adulto, Adulto mais velho)

Aceita Voluntários Saudáveis

Não

Gêneros Elegíveis para o Estudo

Tudo

Descrição

Inclusion Criteria:

  • Over 18 years
  • Can communicate and understand English independently, in a way that would meet the B2 reference level in the CEFR global scale
  • Experiencing post-traumatic stress or diagnosed with PTSD
  • Has difficulties regulating emotions assessed as in clinical assessment from the Community Forensic Team
  • Have committed a violent offence which they have been charged with.

Exclusion Criteria:

  • Anyone who is presenting as acutely unwell, or struggling with active suicidal ideation, with plans and intent. Due to the nature of the therapy as stated above, and exposure to memories of potentially traumatic life events, it would not be suitable to conduct the therapy with those presenting with active risk to self.

Plano de estudo

Esta seção fornece detalhes do plano de estudo, incluindo como o estudo é projetado e o que o estudo está medindo.

Como o estudo é projetado?

Detalhes do projeto

  • Finalidade Principal: Tratamento
  • Alocação: N / D
  • Modelo Intervencional: Atribuição de grupo único
  • Mascaramento: Nenhum (rótulo aberto)

Armas e Intervenções

Grupo de Participantes / Braço
Intervenção / Tratamento
Experimental: Narrative Exposure Therapy Treatment

Participants will receive narrative exposure therapy

Narrative Exposure Therapy

O que o estudo está medindo?

Medidas de resultados primários

Medida de resultado
Descrição da medida
Prazo
International Trauma Questionnaire
Prazo: From enrolment to the end of treatment. 3 week baseline Phases starting from Week 1, and then administered weekly following this until the end of treatment. This will be up to 20 sessions.

Trauma Questionnaire that is based on the ICD 11 criteria for PTSD diagnosis. It is a Likert scale with scores ranging from 0-5. The higher the score the more symptoms individuals have.

From enrolment to the end of treatment. 3 week baseline Phases starting from Week 1, and then administered weekly following this until the end of treatment. This will be up to 20 sessions.

Medidas de resultados secundários

Medida de resultado
Descrição da medida
Prazo
Difficulties in Emotion Regulation Scale -16
Prazo: Before intervention at week 2 of the baseline phase and after intervention on the final session which could be up to session 20.

A measure of emotion regulation. It is a Likert scale indicating with scores from 0-5, with higher scores indicating more difficulties in emotion regulation.

Before intervention at week 2 of the baseline phase and after intervention on the final session which could be up to session 20.
CORE-10
Prazo: From enrolment to the end of treatment. 3 week baseline Phases starting from Week 1, and then administered weekly following this until the end of treatment. This will be up to 20 sessions.

A measure of general wellbeing. A likert scale with scores from 0-5 with higher scores indicating worse overall wellbeing and lower scores indicating better overall wellbeing

From enrolment to the end of treatment. 3 week baseline Phases starting from Week 1, and then administered weekly following this until the end of treatment. This will be up to 20 sessions.
Heart Rate Variability
Prazo: To be administered after the 3 week baseline Phases, when trauma processing commences, starting from Week 2 of the experimental phase, and then administered weekly following this until the end of treatment. This will be up to 20 sessions.
To be administered after the 3 week baseline Phases, when trauma processing commences, starting from Week 2 of the experimental phase, and then administered weekly following this until the end of treatment. This will be up to 20 sessions.

Colaboradores e Investigadores

É aqui que você encontrará pessoas e organizações envolvidas com este estudo.

Patrocinador

Investigadores

  • Investigador principal: Rebecca Watson, University of Lincoln

Datas de registro do estudo

Essas datas acompanham o progresso do registro do estudo e os envios de resumo dos resultados para ClinicalTrials.gov. Os registros do estudo e os resultados relatados são revisados ​​pela National Library of Medicine (NLM) para garantir que atendam aos padrões específicos de controle de qualidade antes de serem publicados no site público.

Datas Principais do Estudo

Início do estudo (Real)

23 de junho de 2026

Conclusão Primária (Estimado)

18 de dezembro de 2026

Conclusão do estudo (Estimado)

18 de dezembro de 2026

Datas de inscrição no estudo

Enviado pela primeira vez

5 de novembro de 2026

Enviado pela primeira vez que atendeu aos critérios de CQ

11 de novembro de 2026

Primeira postagem (Real)

17 de novembro de 2026

Atualizações de registro de estudo

Última Atualização Postada (Real)

17 de novembro de 2026

Última atualização enviada que atendeu aos critérios de controle de qualidade

11 de novembro de 2026

Última verificação

1 de novembro de 2026

Mais Informações

Termos relacionados a este estudo

Plano para dados de participantes individuais (IPD)

Planeja compartilhar dados de participantes individuais (IPD)?

NÃO

Informações sobre medicamentos e dispositivos, documentos de estudo

Estuda um medicamento regulamentado pela FDA dos EUA

Não

Estuda um produto de dispositivo regulamentado pela FDA dos EUA

Não

Essas informações foram obtidas diretamente do site clinicaltrials.gov sem nenhuma alteração. Se você tiver alguma solicitação para alterar, remover ou atualizar os detalhes do seu estudo, entre em contato com register@clinicaltrials.gov. Assim que uma alteração for implementada em clinicaltrials.gov, ela também será atualizada automaticamente em nosso site .

Se inscrever